Tinnitus is described as a disturbing sound sensation in the absence of external stimulation. We aimed to investigate whether there is any relationship between severe chronic tinnitus and angiotensin-converting enzyme (ACE) I/D and α-adducin (ADD1) G460W gene polymorphisms.
INTRODUCTION
Tinnitus is described as a disturbing sound sensation in the absence of external stimulation [1] . Tinnitus, which is one of the most common symptoms of the auditory system, is a symptom of many diseases. Characteristically, the prevalence of tinnitus increases by age. The estimated prevalence of tinnitus in the general population varies from 3% to 30%. Tinnitus concerns approximately 15% of the general population, 10-15% of which experience severe chronic tinnitus. The prevalence is higher in elderly patients and in workers exposed to industrial noise than in the general population [2, 3] .
For tinnitus, a limited number of risk factors have been suggested, including increasing age, hypertension, hearing loss, loud noise exposure, dietary factors, ototoxic drugs, elevated blood lipids, and alcohol consumption [4] [5] [6] . Approximately 50% of patients with tinnitus are not attributed to any above mentioned causes; for this reason, inter-individual predisposition to tinnitus might be explained by the effect of genetic factors [4] [5] [6] [7] [8] .
Angiotensin-converting enzyme (ACE) is an enzyme that plays a crucial role in the renin-angiotensin system. The ACE-coding gene is located on chromosome 17q and has two alleles: deletion (D) and insertion (I). ACE I/D polymorphism has been associated with vascular disorders such as hypertension, coronary artery disease, diabetic or non-diabetic nephropathy, and cerebrovascular disease [9] . Cardiovascular and body water regulation are regulated by the renin-angiotensin system, which is a hormone system. One of the reasons for pulsatile or non-pulsatile tinnitus may be the cardiovascular and body water regulation alterations related to ACE via cerebral blood flow and flow-related noise alterations [10] .
By interacting with the epithelial sodium channel, α-adducin (ADD1) exerts crucial and complex biological effects on volume and sodium homeostasis. An ADD1 polymorphism of codon 460, coding the substitution of tryptophan (Trp) in place of glycine (Gly) (Gly460Trp), has been reported to be linked to elevated blood pressure, sensitivity to salt, and cardiovascular diseases. Adducin is involved in signal transduction mechanisms by modulating the actin cytoskeleton at cell-cell contact sites. There is a lot of experimental evidence indicating that adducin may be a candidate protein in primary or essential hypertension [11, 12] . It has been shown that the organ of corti and stria vascularis are the primary lesion sites in hypertension [13] . Endolymph, perilymph, and intrastrial spaces play important role in ion and fluid balance in the inner ear. The Na + -K + -ATPase transporter is need for K + secretion into the endolymph because the intrastrial space has a lower K + concentration than endolymph. Na + -K + transporters play an important role in K + secretion into the endolymph and the accumulation of K + in the intrastrial fluid [14] . The K + inside the intrastrial space and perilymph is absorbed by strial marginal cells and vestibular dark cells via the Na + -K + -ATPase pump and the Na + -2Cl-K + transporter [15] . The absence of Na + -K + transporters creates an interruption in secretion of K + into the endolymph and generates a failure in the endocochlear potential [14] . Kuijper and Bonting [16] demonstrated that ouabain causes an interruption of K + secretion and disrupts the endocochlear potential by blocking the Na [17] . This increased activity may result in an increased volume and endolymph osmolarity [17, 18] . Angiotensin-converting enzyme I/D polymorphism and (ADD1) G460W polymorphism have been previously associated to hypertension and there may be a possible association with severe chronic tinnitus. In the light of this information, we aimed to investigate the relationship between (ACE) I/D and (ADD1) G460W gene polymorphisms and severe chronic tinnitus.
MATERIALS and METHODS

Patients
The total number of individuals included in this study was 193. The patient group and control group consisted of 89 and 104 individuals, respectively. Between 2006-2013, patients suffering from severe chronic tinnitus for more than 6 months were retrieved from the medical records and the patients were invited to the Hospital, and informed consent forms were taken at Department of Otorhinolaryngology, Gaziosmanpaşa University, Tokat. The control group was selected from individuals without any otologic or systemic diseases. The patients and controls in the current study were from the same geographic region (central Anatolia region of Turkey) and the same ethnic origin (Turkish-Caucasian). Moreover, approval of the ethical committee was taken from Clinical Research Ethics Committee of Gaziosmanpaşa University.
Study Design
This study was conducted in patients who had been diagnosed with tinnitus for more than 6 months and who were older than 18 years. In the present study, exclusion criteria were determined as follows: patients having acute and objective tinnitus, sensorineural hearing loss, ear infection, external or middle ear problem, chronic otitis media, otosclerosis, vestibular schwannoma, Ménière's disease, otorrhea, temporal bone trauma history, psychiatric disorder, previous ear surgery history, previous neurotologic surgery history, ototoxicity history, smoking habit, diabetes mellitus, hypertension, cardiovascular disease, hypothyroidism, hypercholesterolemia, hyperlipidemia, head trauma, and known hyperacusia.
The evaluation of tinnitus was performed using the Strukturiertes Tinnitus-Interview (STI); a decrease of at least 35% of the initial score was considered clinically significant. The Tinnitus Handicap Inventory (THI) was used to evaluate the tinnitus severity. Patients were assessed on the basis of 100 points; 58-76 points were accepted as severe tinnitus.
Genotyping
Peripheral blood samples obtained both from patients with tinnitus and from the control groups were collected in tubes with K 3 EDTA and stored at −20°C until the study time. Total genomic DNA was extracted from peripheral blood samples using the Invisorb Spin Blood extraction kit (Invitek; Berlin, Germany). PCR and RFLP conditions, using primers and/or restriction endonucleases and fragment lengths of the detected genotypes, were shown in Table 1 .
Statistical Analysis
Statistical analyses in the present study were performed using the Statistical Package for the Social Sciences version 15.0 (SPSS; Chicago, IL, USA) package program. The Chi-square test was used to compare the differences between the groups in terms of frequencies of genotypes and alleles. The Student-t test was performed to compare the demographic data of the groups. Allele frequencies were assessed by the gene counting method. The odds ratio (OR) values were given with 95% confidence intervals. P<0.05 was regarded as significant. There was no difference between the groups in terms of sex and age. When the patient and control groups were compared in terms of ACE genotype distribution, no significant difference was observed (X 2 =1.586, p=0.452) ( Table 2 ). On the other hand, in terms of, the GW genotype of ADD1 G460W was found to be significantly higher in the patient group than that of control group (X 2 =9.4, p=0.009) ( Table  2 ). In terms of ACE allele frequencies, there was no significant difference between the patient and control groups (X 2 =0.7, p=0.4) ( Table  2 ). On the other hand, in terms of ADD1 G460W alleles, the W allele was found to be significantly higher in the patient group than that of the control group (X 2 =5.3, p=0.021) ( Table 2 ). It was found that the GW genotype increased the disease risk by 2.5-fold compared with the other genotypes (Table 3) .
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When ACE I/D and ADD1 G460W genotypes were evaluated together, the II/GW genotype was found to be statistically significantly higher in the patient group than that of the control group (X 2 =7.15, p=0.007). II/WW and DD/WW genotypes were observed neither in the patient group nor in the control group. The distributions of other combined genotypes of ACE I/D and ADD1 G460W were shown in Table 4 .
DISCUSSION
The etiology of chronic tinnitus remains poorly understood. There is lots of evidence that genetic factors are predisposed to chronic tinnitus [19] . In the present study, we studied ACE and ADD1 gene polymorphisms to show any possible role on the pathophysiology of severe chronic tinnitus.
Our study is the first to show that there is a possible association between G460W polymorphism and the pathophysiology of tinnitus. A number of studies have suggested that ADD1 Trp allele poses a higher risk for cardiovascular and renal diseases [20] [21] [22] . Morrison et al. [23] claimed that ADD1 Trp allele increases the coronary heart disease risk by a factor of 2-fold and Sugimoto et al. [24] reported that Gly460Trp polymorphism is a marker of deteriorating health. Tinnitus often presents in adults with Ménière's disease [25] . Teggi et al. [26] found similar results to our study. They reported that the Trp allele frequency of ADD1 G460W polymorphism was significantly increased in patients with Ménière's disease compared to controls.
There have been many studies showing a strong relationship between α-adducin gene G460W polymorphism and essential hypertension. It has been shown that especially individuals with the W allele have an increased risk for hypertension [27, 28] . In our study, having a significantly higher GW genotype and W allele in the patient group compared to the controls suggests that α-adducin G460W polymorphism plays a role in the pathophysiology of tinnitus.
Although a wide array of compounds is recommended to treat tinnitus patients, no drug used in the treatment of tinnitus patients on the market has yet been approved by US Food and Drug Administration or European Medicines Agency [29] . Elgoyhen et al. [30] suggested that ACE is a significant target for tinnitus, and to the best of the authors' knowledge, this was the first time it was determined to be related to tinnitus. According to the authors, the potential role of the brain renin-angiotensin system has been recommended for auditory attention. In this way, this system might attend in tinnitus-related sound and auditory attention and affective brain circuits.
Genetic studies conducted on tinnitus are very limited and are particularly focused on candidate-gene association studies. In a study, Hwang et al. [31] demonstrated that salicylate-induced tinnitus correlated with the increased gene expression of TNF-α and IL-1β. Deniz et al. [32] investigated the possible role of serotonin transporter gene (SLC6A4) polymorphisms in tinnitus. They did not find any difference between the allele and genotype frequencies of the patients with tinnitus and with the controls regarding VNTR and 5-HTTLPR polymorphisms. Also they found no association between SLC6A4 polymorphism and the psychoacoustic parameters of tinnitus. On the other hand, they found a significant relationship between 5-HTTLPR polymorphism and the visual analog scale scores of the patients. In another study, authors investigated the effect of acute and chronic salicylate treatment on the expression of NR2B, Arg3.1, and Egr-1 in an animal model of tinnitus, and they found both mRNA levels and the protein expression of NR2B and Arg3.1 increased in rats that were chronically administered salicylate [33] . In a study conducted with inner ear potassium recycling genes, significant associations were observed for two variants in KCNE1 and one SLC12A2 gene [34] . Furthermore, Sand et al. [35] reported that GDNF genotypes together with BDNF genotypes predict tinnitus severity in women but not in men.
Voltage-gated ion channels are known to be strong candidates related with the studies of the pathophysiology of tinnitus [36, 37] . It has been shown that α-adducin increased the Na + -K + -ATPase pump activity [17] . Consequently, this increased activity may result in an increased volume and endolymph osmolarity [17, 18] . The identification of possible contribution of α-adducin to the activity of Na Hereditary and environmental factors play important roles in the etiology of tinnitus. Further studies are necessary for clarifying genetic contributions to the pathophysiology of tinnitus. Furthermore, genetic tests can be useful when individual genetic variants are found to determine responsiveness to pharmacological therapy [38] . Our results indicate that additional studies must be undertaken to determine whether one or both genes have any role in the pathogenesis of tinnitus.
In conclusion, although ACE I/D polymorphism did not show any difference between the patient group and control group, there was a significant difference in terms of genotype distribution and allele frequencies of ADD1 G460W gene polymorphism. Further studies should be carried out to explain the combined effect of gene-gene interactions, environmental factors, and individual biological characteristics for understanding the potential mechanism of the pathophysiology of tinnitus in humans. The efficiency and accuracy of our results should be increased and supported by results obtained in studies on larger populations.
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